Report error Found 179 Enz. Inhib. hit(s) with Target = 'Casein kinase I isoform gamma-2'
Affinity DataIC50: 2nMAssay Description:Inhibition of human CK1g2 using KRRRAL[pS]VASLPGL as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 m...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 80nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 87nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
Affinity DataKd: 87nMAssay Description:Binding affinity to human CSNK1G2 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Affinity DataKd: 100nMAssay Description:Binding affinity to CSNK1G2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataKd: 110nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 110nMAssay Description:Binding constant for full-length CSNK1G2More data for this Ligand-Target Pair
Affinity DataKd: 110nMAssay Description:Binding affinity to CSNK1G2More data for this Ligand-Target Pair
Affinity DataKd: 110nMAssay Description:Binding constant for CSNK1G2 kinase domainMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
Affinity DataIC50: 254nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
Affinity DataKd: 270nMAssay Description:Binding affinity to CSNK1G2 assessed as dissociation constantMore data for this Ligand-Target Pair
Affinity DataIC50: 348nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
Affinity DataKd: 380nMAssay Description:Binding constant for CSNK1G2 kinase domainMore data for this Ligand-Target Pair
Affinity DataIC50: 394nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
Affinity DataIC50: 537nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
Affinity DataKd: 580nMAssay Description:Binding constant for CSNK1G2 kinase domainMore data for this Ligand-Target Pair
Affinity DataIC50: 584nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
Affinity DataIC50: 700nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
Affinity DataKd: 740nMAssay Description:Binding constant for full-length CSNK1G2More data for this Ligand-Target Pair
Affinity DataKd: 740nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 780nMAssay Description:Binding constant for full-length CSNK1G2More data for this Ligand-Target Pair
Affinity DataKd: 780nMAssay Description:Binding constant for CSNK1G2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 780nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 790nMAssay Description:Binding constant for full-length CSNK1G2More data for this Ligand-Target Pair
Affinity DataKd: 790nMAssay Description:Binding constant for CSNK1G2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 790nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataIC50: 840nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
Affinity DataIC50: 853nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
Affinity DataKd: 950nMAssay Description:Binding constant for CSNK1G2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 950nMAssay Description:Binding constant for full-length CSNK1G2More data for this Ligand-Target Pair
Affinity DataKd: 950nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of CSNK1G2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of CSNK1G2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.17E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
Affinity DataIC50: 1.37E+3nMAssay Description:Inhibition of human CK1gamma2 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair





























